A phase I study of cloretazine (VNP40101M) [laromustine] and temozolomide in patients with hematologic malignancies
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2013
At a glance
- Drugs Laromustine (Primary) ; Temozolomide
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 04 Jun 2007 Status changed from recruiting to in progress.
- 08 Sep 2005 New trial record.